Public Media from Michigan State University
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Why FDA approval of sickle cell gene therapy is a ‘big deal’

Season 2023 Episode 354 | 5m 08s

Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.

Major corporate funding for the PBS News Hour is provided by BDO, BNSF, Consumer Cellular, American Cruise Lines, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Consumer Cellular and Cunard Cruise Line. For a complete list of funders for the PBS NewsHour and PBS NewsHour weekend, click here.
Extras
July 2, 2026 - PBS News Hour full episode
As Venezuela crisis deepens, Chef José Andrés feeds earthquake survivors and search teams
How legal battles across the country could complicate the midterms
Russia pounds Kyiv with missiles and drones after Ukraine's strikes on oil infrastructure
Haberman and Swan on 'Regime Change,' their book on Trump's unconstrained 2nd term
Hard-fought win raises hopes for U.S. in World Cup
A look at America's founding from the room where independence was declared
News Wrap: Former U.S. Olympian faces felony charge for alleged Reflecting Pool vandalism
America at 250: New poll finds nation divided over its identity and future
'We're not stopping': Virginia rescue team searches for quake survivors in Venezuela